Literature DB >> 12419648

Pentoxifylline diminished acetaldehyde-induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression.

E Hernández1, A Correa, L Bucio, V Souza, D Kershenobich, M C Gutiérrez-Ruiz.   

Abstract

The effect of pentoxifylline (PTX), a methylxanthine derivative, on collagen induction and secretion and on the production of mRNA of two fibrogenic cytokines: interleukin-6 and transforming growth factor-beta(1) (IL-6 and TGF-beta(1)) in a rat hepatic stellate cell line (CFSC-2G) exposed to acetaldehyde was studied. CFSC-2G cells were treated with 175 microM acetaldehyde for 24h. The cells were then exposed to a medium containing 200 microM PTX. Collagen secretion, increased 2.6 times in acetaldehyde treated cells. Cells exposed to acetaldehyde and treated with PTX diminished collagen secretion to control values and decreased alpha(1)(I) collagen mRNA by 15%. Reverse transcriptase-polymerase chain reaction (RT-PCR) assays of TGF-beta(1) mRNA showed no variation in different experimental conditions. However, PTX induced a decrease of 32% in IL-6 mRNA in acetaldehyde-treated cells. CFSC-2G cells treated with anti-IL-6 monoclonal antibody, 15min before acetaldehyde was added, did not present an increase in alpha(1)(I) collagen mRNA. These results show that PTX inhibits the expression of alpha(1)(I) collagen via the inhibition of IL-6 in acetaldehyde treated cells. The effect herein reported on IL-6 and alpha(1)(I) collagen mRNA adds to the previously described effect of PTX, which could be useful in the fibrogenic process induced by acetaldehyde.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419648     DOI: 10.1016/s1043661802002025

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  11 in total

1.  Pentoxifylline in patients with oral submucous fibrosis-a randomized clinical trial.

Authors:  Namdeo Prabhu; Sanjay S Rao; S M Kotrashetti; Shridhar D Baliga; Seema R Hallikerimath; Punnya V Angadi; Rakhi Issrani
Journal:  J Maxillofac Oral Surg       Date:  2013-09-13

Review 2.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

3.  Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.

Authors:  Claudia O Zein; Lisa M Yerian; Prema Gogate; Rocio Lopez; John P Kirwan; Ariel E Feldstein; Arthur J McCullough
Journal:  Hepatology       Date:  2011-08-24       Impact factor: 17.425

Review 4.  Role of ethanol in the regulation of hepatic stellate cell function.

Authors:  Jian-Hua Wang; Robert-G Batey; Jacob George
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

5.  Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis.

Authors:  N Ohnishi; T Miyata; H Ohnishi; H Yasuda; K Tamada; N Ueda; H Mashima; K Sugano
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression.

Authors:  Qiu-gen Zhou; Fa-lei Zheng; Fan-fan Hou
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

7.  Medicinal management of oral submucous fibrosis in the past decade- A systematic review.

Authors:  Chandramani B More; Deepa Jatti Patil; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

8.  Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.

Authors:  David Wayne Johnson; Carmel Mary Hawley; Brenda Rosser; Elaine Beller; Charles Thompson; Robert G Fassett; Paolo Ferrari; Stephen MacDonald; Eugenie Pedagogos; Alan Cass
Journal:  BMC Nephrol       Date:  2008-08-01       Impact factor: 2.388

Review 9.  Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic.

Authors:  Marialena Mouzaki; Johane Allard
Journal:  Ann Gastroenterol       Date:  2012

10.  Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran.

Authors:  Nadieh Baniasadi; Faranak Salajegheh; Abbas Pardakhty; Seyed Mehdi Seyedmirzaee; Mohammad Mahdi Hayatbakhsh; Amin Reza Nikpoor; Mojgan Mohammadi
Journal:  Hepat Mon       Date:  2015-11-28       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.